Collaborations & Alliances
Related Searches:
Filter by:
436 - 450 of 1093 results
May 3, 2011
Icagen and Pfizer have entered into a collaboration with the Yale School of Medicine to investigate potential new pain compounds identified by Icagen and Pfizer in their existing collaboration.
Read More »
April 29, 2011
PSI to gain preferred access to VitalDose EVA for early-stage projects
Read More »
April 29, 2011
Stability storage services added to Velesco's development offerings.
Read More »
April 26, 2011
Pharmacyclics, Inc. has received a $7 million milestone payment from Les Laboratoires Servier (Servier) for its histone deacetylase (HDAC) inhibitor, PCI-24781 / S 78454.
Read More »
April 25, 2011
OncoMed Pharmaceuticals and Bayer HealthCare have expanded their collaboration under which Bayer will manufacture clinical supplies of a second Wnt inhibitor.
Read More »
April 20, 2011
Gilead Sciences and MicroDose Therapeutx have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose’s inhalable small molecule antiviral fusion inhibitor for the treat
Read More »
April 19, 2011
Doe & Ingalls and BioVectra have renewed and expanded their partnership agreement.
Read More »
April 19, 2011
Genmab and Seattle Genetics have entered into their second antibody-drug conjugate (ADC) research collaboration under which Genmab has rights to use Seattle Genetics’ ADC technology with HuMax-CD74.
Read More »
April 18, 2011
Sanofi-Aventis has entered a research collaboration through the Stanford University Bio-X program that supports, organizes and facilitates collaborative research projects in the early phases of development.
Read More »
April 13, 2011
Amunix, Inc. has entered into an exclusive worldwide research collaboration with Biogen Idec to research and develop novel, fully-recombinant blood factors (Factors IX, VIII and VIIa) with improved therapeutic properties.
Read More »
April 13, 2011
Dimerix Bioscience Pty Ltd. has entered into a second research program with Takeda Cambridge Ltd., a UK based subsidiary of Takeda Pharmaceutical Co.
Read More »
April 12, 2011
Pieris AG has entered into a collaboration and license agreement with Daiichi Sankyo Co. Ltd., under which Pieris will apply its Anticalin scaffold technology to discover novel Anticalins against two Daiichi Sankyo targets.
Read More »
April 12, 2011
Orasi Medical has entered into an agreement with Biogen Idec to test novel biomarkers for the development of treatments for central nervous system (CNS) disorders.
Read More »
April 11, 2011
Merck & Co. and Sun Pharmaceutical Industries have created a joint venture to develop, manufacture and commercialize new combinations and formulations of branded generics in emerging markets.
Read More »
April 8, 2011
Impax Laboratories has entered into a collaboration with Banner Pharmacaps to supply and commercialize two undisclosed softgel capsule products.
Read More »
436 - 450 of 1093 results
